Is the future of disease management digital?Download the full report
Adding artificial intelligence (AI) and sensors to existing therapies, digital therapy complements traditional medicine with patient personalization and individualization. Our research shows that 63 percent of healthcare professionals surveyed rank individualizing treatment as the #1 benefit of digitally supported therapies.
AI used in digital therapy might help patients with diabetes to achieve and maintain optimal blood glucose levels. AI enabled-inhalers are helping patients with COPD spend more days symptom free, and less time in the emergency room.
Digital therapy isn’t a direct replacement for a pharmaceutical intervention, or meant to provide a placebo effect. But it might be a useful adjunct to traditional therapy.
How can IBM help you?
Systems of care are transforming. Organizations are converging and new partnerships are forming. Meeting modern demands requires developing essential technologies for the healthcare industry of the future.
Meet the Authors:Lars Böhm, Associate Partner, Life Sciences, IBM Global Business Services, Alexander Büsser, Managing Data Science Consultant, Digital Health, IBM Global Business Services, Karen Pesse, Consultant, IBM Global Business Services, Sumehra Premji, Senior Managing Consultant, IBM Global Business Services, Yannick Klopfenstein, Senior Consultant and Data Scientist, IBM Global Business Services, Delphine Hajaji, Venture Fund Partner, UCB, Matthias Schieker, Executive Director, Translational Medicine Musculoskeletal Diseases, Novartis Institute for Biomedical Research, Dr. Bernd Schneidinger, International Business Lead, Roche Diabetes Care GmbH, Heather Fraser, Global Lead for Healthcare and Life Sciences, IBM Institute for Business Value